IL Monthly Puff: Illinois’ Final 2020 Lottery Lawsuit Hits Ruling Day, DOJ Moves Medical Cannabis to Schedule III May 2026

Illinois Cannabis: Lottery Ruling, Federal Schedule III, and a New MSO Class Action May 2026

Illinois cannabis saw major movement this spring. A Cook County judge is set to rule on the last 2020 lottery lawsuit on May 21, federal rescheduling has reshaped the medical market, the delayed Kewanee dispensary cleared inspection, and a federal class action puts three Chicago MSOs on the defensive. In the background, IDOA’s proposed plant monitoring system and fee cuts, first published in fall 2025, remain pending final adoption.

Top Headlines This Month

• ⚖️ Final 2020 social equity lottery lawsuit reaches its ruling date
• 🏛️ DOJ final order moves state medical cannabis to Schedule III
• 🏪 Kewanee dispensary passes inspection, awaits state license
• ⚠️ Class action targets Cresco, GTI, and Verano over marketing claims
• 🏛️ IDOA’s proposed plant monitoring rules and fee cuts still pending final adoption

⚖️ ILLINOIS: FINAL SOCIAL EQUITY DISPENSARY LAWSUIT REACHES RULING DATE

Well-Being Holistic Group, a social equity applicant that received perfect scores on all four of its dispensary license applications, had its day in Cook County court during the week of April 1, 2026. It was the last of dozens of lawsuits filed following the 2020 cannabis licensing lottery. Well-Being argues that the Illinois Department of Financial and Professional Regulation allowed roughly 450 ineligible entries into a pool of 901 applicants for Chicago-region dispensary licenses, nearly doubling the pool and reducing other applicants’ odds of winning. The plaintiff alleges those entries were backed by existing corporate cannabis companies, pointing to one case where a company paid roughly $500,000 in application fees with its name appearing as remitter on cashier’s checks. The state countered that its vetting covered principal officers as required, and that even if the contested applications were removed, Well-Being would have placed 126th out of 450 and would not have won a license. Judge Patrick Stanton was scheduled to issue his ruling at a hearing on May 21, 2026. As of January 2026, only 64% of licensed social equity dispensaries were operational, according to a Crain’s Chicago Business analysis, with nearly 100 still sitting on unused licenses. The first social equity dispensaries did not open until November 2022, nearly three years after the application process opened. A ruling requiring a corrective lottery would reopen the Chicago-region licensing pool. A ruling for the state closes out this final round of challenges to the 2020 lottery process.

Source:
https://www.wqad.com/article/news/politics/illinois-politics/7-years-after-legalization-final-illinois-cannabis-licensing-lawsuit-goes-to-court/526-a42e460a-19da-4d97-92e1-59c00d3d8891

🏛️ FEDERAL: DOJ FINAL ORDER MOVES STATE-LICENSED MEDICAL CANNABIS TO SCHEDULE III

Acting Attorney General Todd Blanche signed a final order on April 23, 2026, transferring FDA-approved marijuana products and all cannabis subject to a state medical marijuana license from Schedule I to Schedule III of the Controlled Substances Act. The order takes effect on publication in the Federal Register (April 28, 2026) and creates a pathway for state-regulated medical cannabis businesses to operate under both state and federal controlled substances law. State-licensed medical cannabis companies have 60 days from publication to apply for DEA registration, and those that apply within that window can continue operating under their state licenses while DEA reviews their applications. Relief from Internal Revenue Code Section 280E, which previously barred standard business deductions for Schedule I and II substance handlers, is expected to apply for the 2026 tax year, though legal analyses differ on the precise effective date. The order references January 1, 2026 for calendar-year taxpayers, while some firms read the relief as prospective from late April 2026. Treasury has announced it will issue guidance to confirm the transition rule, and retroactive relief for prior years is encouraged by the order but remains subject to separate Treasury guidance. The order excludes recreational cannabis, and a DEA Administrative Law Judge hearing on the broader formal rescheduling rulemaking is scheduled to begin June 29, 2026, and conclude no later than July 15, 2026. The anticipated 280E relief for the 2026 tax year stands to improve cash flow and profitability across the licensed medical sector, though the final shape of that benefit depends on Treasury guidance and the outcome of expected legal challenges. Businesses holding both medical and adult-use licenses face an open question, as the order does not clarify whether and how DEA will require those operations to be structured to qualify for registration.

Source:
https://natlawreview.com/article/doj-final-order-rescheduling-marijuana-key-implications-guidance-and-opportunities

🏪 KEWANEE: TRICHOME CANNABIS COMPANY DISPENSARY PASSES STATE INSPECTION, LICENSE IMMINENT

A cannabis dispensary in the 600 block of Tenney Street in Kewanee, Illinois, passed its state inspection in May 2026 and is waiting on its state license before opening. Investor and Vice President Chad Anderson said as of May 11, 2026, he hoped the license would arrive within about a week. The facility was remodeled from a former restaurant over roughly a year and a half of work. State inspectors required three additional surveillance cameras before approving the facility, bringing the total camera count to 75. The company, now named Trichome Cannabis Company following a leadership change, has put approximately $1.3 million into the dispensary remodel and a separate grow facility under construction at Railroad Avenue and Cole Street, not including the building purchase price. The grow facility is expected to open by the end of 2026. Until then, the dispensary will source product from other Illinois grow operations. The Kewanee opening concludes roughly a year and a half of remodeling work and marks the start of what Trichome Cannabis Company is building as a vertically integrated operation in the region. Once the grow facility comes online later this year, the company will shift from sourcing externally to supplying the dispensary from its own cultivation.

Source:
https://kewaneevoice.com/cannabis-dispensary-passes-inspection-will-open-soon/

⚠️ ILLINOIS: FEDERAL CLASS ACTION TARGETS CRESCO, GTI, AND VERANO OVER MARKETING CLAIMS

A federal class action lawsuit, Murray et al. v. Cresco Labs Inc. et al., was filed May 4, 2026 in the U.S. District Court for the Northern District of Illinois on behalf of more than 40 customers across 12 states. It names three Chicago-based cannabis companies: Cresco Labs Inc., Green Thumb Industries Inc., and Verano Holdings Corp. The 320-page complaint alleges the companies made false or misleading marketing claims about the benefits of their products to recreational consumers and downplayed health risks, raising claims under RICO, consumer fraud, and negligent misrepresentation. The complaint explicitly focuses on adult-use purchases. The suit seeks disgorgement of all monies wrongfully obtained, restitution, a prohibition on false marketing claims, and required consumer warnings about product dangers. Companion litigation targeting Curaleaf Holdings Inc. was filed separately in Marion County, Illinois, and in Connecticut. A study found that 67% of dispensary websites made health claims, and a 2025 Journal of the American Medical Association analysis of 124 studies found evidence is insufficient for the use of cannabis or cannabinoids for most medical indications. Verano responded that the lawsuit mirrors claims already rejected by courts in similar actions earlier this year. The suit arrives against the backdrop of federal rescheduling, which formally acknowledges cannabis has accepted medical use, a tension the lawsuit and its defendants will both have to contend with. The complaint concerns adult-use purchases rather than the state-licensed medical market, so the marketing claims at issue run to recreational sales, not Illinois’s medical patient base.

Source:
https://mjbizdaily.com/news/cannabis-msos-sued-in-federal-court-over-deceptive-medical-marketing-claims/615837/

🏛️ ILLINOIS: IDOA’S PROPOSED CANNABIS PLANT MONITORING SYSTEM AND FEE CUTS REMAIN PENDING

The Illinois Department of Agriculture published proposed amendments under the Cannabis Regulation and Tax Act in fall 2025 that would extend IDOA licensing and regulation, previously limited to cultivation centers, to craft growers, infusers, processors, and community college cannabis vocational pilot programs. IDOA held its public hearing on the proposal on October 20, 2025, and the rules are still moving through the Illinois administrative rulemaking process and have not yet been finally adopted. The proposed rules would establish a statewide Illinois cannabis plant monitoring system requiring all licensed establishments to maintain accounts, track all cannabis movements through plant tags and manifests, and record every cultivation and production activity. As proposed, starting July 1, 2026, licensed cannabis business establishments could not incorporate, manufacture, or transport any product containing cannabis, hemp, industrial hemp or any cannabis plant material not cultivated by a licensed Illinois cannabis business establishment. On the fee side, application fees for major modifications are proposed to be cut across the board: cultivation centers would drop to $4,000 (previously $5,000 at application and $3,000 upon approval), craft growers to $2,000 (previously $2,500 at application and $1,500 upon approval), and infusers to $1,000 (previously $1,250 at application and $750 upon approval). The $1,000 principal officer change fee would be eliminated entirely, the product registration fee would fall from $100 to $25, and craft growers and infusers would be exempt from annual renewal fees for two renewal periods after the rulemaking takes effect. The proposed fee reductions would lower the cost of modifying and maintaining licenses for smaller cannabis producers, while the proposed monitoring system would extend IDOA oversight to the full production chain. The July 1, 2026 sourcing restriction, which would bar use of any cannabis, hemp, industrial hemp or any cannabis plant material not cultivated by a licensed Illinois cannabis business establishment, would give establishments a firm deadline to review their input supply chains, but only if and when the rules become final.

Source:
https://illinoisnewsjoint.com/idoa-proposes-new-cannabis-plant-monitoring-system/

Illinois Cannabis Acquisition Opportunities

Contact us to discuss further

The Bottom Line

Spring 2026 reshaped Illinois cannabis on multiple levels: the final 2020 lottery ruling reaching its decision date, federal Schedule III relief taking effect for medical operators, and the delayed Kewanee dispensary clearing inspection. A federal class action against three Chicago MSOs adds new legal pressure even as rescheduling formally recognizes medical use, all while IDOA’s proposed plant monitoring system and fee cuts continue to await final adoption.